Home LiteratureArticle Details
PMID: 3421959 Published · ppublish English Journal Article

Carrier-mediated uptake of cephalexin in human intestinal cells.

Biochemical and biophysical research communications ·Vol. 155 ·No. 2 ·1988-09-15 ·Pages 1082-7

Dantzig AH, Bergin L

Abstract

A transport carrier for cephalexin, a cephalosporin antibiotic, was identified in a human intestinal cell line, HT-29. Uptake via the carrier was inhibited by dipeptides, phe-gly, gly-pro, carnosine, and cefaclor, a close drug analog. Uptake was unaffected by the presence of amino acids. The pH optimum for uptake was 6.2. Drug uptake was not dependent on the presence of sodium and was insensitive to metabolic inhibitors. The efflux of cephalexin was stimulated by extracellular carnosine, indicating counter-transport. Taken together, drug uptake is mediated by a dipeptide transport carrier and not by an amino acid transport carrier. This is the first demonstration of the carrier in an established cell line.

MeSH Terms
Carnosine/pharmacology Carrier Proteins/metabolism Cefaclor/pharmacology Cell Line Cephalexin/pharmacokinetics Dipeptides/pharmacology Humans Hydrogen-Ion Concentration Intestinal Mucosa/metabolism Intestines/drug effects
Chemicals
Carrier Proteins Dipeptides phenylalanylglycine Cefaclor glycylproline Carnosine Cephalexin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dantzig A H
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285.
Bergin L
Article Info
Journal
Biochemical and biophysical research communications
Abbr.
Biochem Biophys Res Commun
ISSN
0006-291X
Published
1988-09-15
Pages
1082-7
Language
English
Region
United States
NLM ID
0372516
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com